Sonja Bendig
0009-0003-0644-9140
Publication & Citation Trends
Publications
0 total
Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia
Cited by 0
Semantic Scholar
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response
Cited by 0
Semantic Scholar
A Novel Natural Killer Cell Expansion Technology for the Development of Cellular Immunotherapies
Cited by 0
Semantic Scholar
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple Myeloma.
Cited by 0
Semantic Scholar
ALLCatchR, a machine-learning classifier identifies now 20 T-ALL subtypes across cohorts and age groups
Cited by 0
Semantic Scholar
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trial
Cited by 0
Semantic Scholar
IntegrateALL: an end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALL
Cited by 1
Semantic Scholar
IL-1β-induced signaling modulates cytokine release and apoptosis in IDH1-mutant AML
Cited by 0
Semantic Scholar
Research Topics
Acute Lymphoblastic Leukemia research
(29)
Acute Myeloid Leukemia Research
(20)
Chronic Myeloid Leukemia Treatments
(11)
CAR-T cell therapy research
(11)
Chronic Lymphocytic Leukemia Research
(10)
Affiliations
University Medical Center
Hochschule für Angewandte Wissenschaften Kiel
Kiel University
Munich Leukemia Laboratory (Germany)
University Hospital and Clinics